Parkinson's drug

Darts failing to hit bullseye
Biotech

Bial bails after Parkinson’s fail, axing asset over phase 2 miss

Bial has stopped development in a subpopulation of Parkinson’s disease patients after its phase 2b trial missed its primary endpoint.
Nick Paul Taylor Jun 9, 2026 5:22am
White arrow on a road pointing to the rising sun

Hope springs toward Parkinson's phase 3 despite divergent data

Dec 23, 2025 9:00am
White arrow on a road pointing to the rising sun

Ventyx posts Parkinson's data ahead of potential Sanofi talks

Jun 17, 2025 9:05am
A series of dice with a bag on them illustrating cost cuts

Servier severing forces OPM to make 'drastic choices' to adapt

Apr 4, 2025 9:05am
long shot miss basketball hoop fail shoot

Roche's Prothena-partnered Parkinson's prospect fails phase 2b

Dec 19, 2024 4:31am
A mouse in its nest peeks out from a tree

Gain's Parkinson's drug helps mice retain cognitive function

Jul 2, 2024 6:00am